Use of dual energy X‐ray absorptiometry, the trabecular bone score and quantitative computed tomography in the evaluation of chronic kidney disease‐mineral and bone disorders. Issue 3 (March 2017)

• Record Type: Journal Article
• Authors: Pocock, Nicholas
• Is Part Of: Nephrology. Volume 22:Issue 3(2017)supplement 2
• Page Start: 19
• Page End: 21
• Publication Date: 2017-03
• Subjects: osteoporosis -- bone mineral density -- chronic kidney disease -- trabecular bone score -- dual‐energy X‐ray absorptiometry -- quantitative computed tomography; Nephrology -- Periodicals; Kidneys -- Diseases -- Periodicals; Nephrologists -- Periodicals; 616.61; 616.61
• DOI: 10.1111/nep.13016
• Languages: English
• ISSNs: 1320-5358

Abstract

Abstract: In subjects with chronic kidney disease (CKD) who suffer a minimal trauma fracture, the problem is to differentiate between osteoporosis and the various forms of renal bone disease associated with CKD–mineral and bone disorder. This problem is exacerbated by the fact that renal osteodystrophy may coexist with osteoporosis. The World Health Organization's bone mineral density (BMD) criteria for osteopenia ( −2.5 < T‐score < −1.0) and osteoporosis (a T‐score ≤ −2.5) may be used in patients with CKD stages 1–3. In CKD stages 4–5, BMD by dual‐energy X‐ray absorptiometry (DXA) is less predictive and may underestimate fracture risk. The development of absolute fracture risk (AFR) algorithms, such as FRAX® and the Garvan absolute fracture risk calculator, to predict risk of fracture over a given time (usually 10 years) aims to incorporate non‐BMD risk factors into the clinical assessment. FRAX® has been shown to be useful to assess fracture risk in CKD but may underestimate fracture risk in advanced CKD. The trabecular bone score is a measure of grey scale homogeneity obtained from spine DXA, which correlates to trabecular microarchitecture and is an independent risk factor for fracture. Recent data demonstrate the potential utility of the trabecular bone score adjustment of AFR through the FRAX® algorithm in subjects with CKD. Parameters of bone microarchitecture using peripheral quantitative computed tomography (pQCT) or high‐resolution pQCT are also able to discriminate fracture status in subjects with CKD. However, there are at present no convincing data that the addition of pQCT or high‐resolution pQCT parameters to DXA BMD improves fracture discrimination. More advanced estimates of bone strength derived from measurements of micro‐architecture, by QCT‐derived finite element analysis may be incorporated into AFR algorithms in the future.